vs
Side-by-side financial comparison of Orion Properties Inc. (ONL) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $35.2M, roughly 1.3× Orion Properties Inc.). STEM, INC. runs the higher net margin — -33.9% vs -101.7%, a 67.8% gap on every dollar of revenue. On growth, Orion Properties Inc. posted the faster year-over-year revenue change (-8.2% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -13.6%).
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
ONL vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $47.1M |
| Net Profit | $-35.8M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -101.5% | -17.7% |
| Net Margin | -101.7% | -33.9% |
| Revenue YoY | -8.2% | -15.6% |
| Net Profit YoY | -9.3% | 68.8% |
| EPS (diluted) | $-0.63 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $47.1M | ||
| Q3 25 | $37.1M | $38.2M | ||
| Q2 25 | $37.3M | $38.4M | ||
| Q1 25 | $38.0M | $32.5M | ||
| Q4 24 | $38.4M | $55.8M | ||
| Q3 24 | $39.2M | $29.3M | ||
| Q2 24 | $40.1M | $34.0M | ||
| Q1 24 | $47.2M | $25.5M |
| Q4 25 | $-35.8M | $-16.0M | ||
| Q3 25 | $-69.0M | $-23.8M | ||
| Q2 25 | $-25.1M | $202.5M | ||
| Q1 25 | $-9.4M | $-25.0M | ||
| Q4 24 | $-32.8M | $-51.1M | ||
| Q3 24 | $-10.2M | $-148.3M | ||
| Q2 24 | $-33.8M | $-582.3M | ||
| Q1 24 | $-26.2M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -101.5% | -17.7% | ||
| Q3 25 | -185.8% | -33.6% | ||
| Q2 25 | -67.1% | -34.8% | ||
| Q1 25 | -24.4% | -65.0% | ||
| Q4 24 | -85.4% | -84.4% | ||
| Q3 24 | -25.9% | -493.2% | ||
| Q2 24 | -84.1% | -1705.5% | ||
| Q1 24 | -55.4% | -267.0% |
| Q4 25 | -101.7% | -33.9% | ||
| Q3 25 | -186.0% | -62.2% | ||
| Q2 25 | -67.3% | 527.8% | ||
| Q1 25 | -24.6% | -76.9% | ||
| Q4 24 | -85.4% | -91.6% | ||
| Q3 24 | -26.1% | -506.3% | ||
| Q2 24 | -84.2% | -1712.6% | ||
| Q1 24 | -55.6% | -283.9% |
| Q4 25 | $-0.63 | $-4.40 | ||
| Q3 25 | $-1.23 | $-2.84 | ||
| Q2 25 | $-0.45 | $-1.79 | ||
| Q1 25 | $-0.17 | $-0.15 | ||
| Q4 24 | $-0.59 | $-15.29 | ||
| Q3 24 | $-0.18 | $-18.24 | ||
| Q2 24 | $-0.60 | $-71.81 | ||
| Q1 24 | $-0.47 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.4M | $48.9M |
| Total DebtLower is stronger | $465.0M | — |
| Stockholders' EquityBook value | $623.2M | $-249.4M |
| Total Assets | $1.2B | $308.9M |
| Debt / EquityLower = less leverage | 0.75× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.4M | $48.9M | ||
| Q3 25 | $32.6M | $43.1M | ||
| Q2 25 | $17.4M | $40.8M | ||
| Q1 25 | $9.4M | $58.6M | ||
| Q4 24 | $15.6M | $56.3M | ||
| Q3 24 | $16.6M | $75.4M | ||
| Q2 24 | $24.2M | $89.6M | ||
| Q1 24 | $23.6M | $112.8M |
| Q4 25 | $465.0M | — | ||
| Q3 25 | $483.0M | — | ||
| Q2 25 | $483.0M | — | ||
| Q1 25 | $505.0M | — | ||
| Q4 24 | $492.0M | — | ||
| Q3 24 | $485.0M | — | ||
| Q2 24 | $462.0M | — | ||
| Q1 24 | $471.0M | — |
| Q4 25 | $623.2M | $-249.4M | ||
| Q3 25 | $658.8M | $-235.7M | ||
| Q2 25 | $728.0M | $-214.1M | ||
| Q1 25 | $753.5M | $-417.5M | ||
| Q4 24 | $763.9M | $-398.4M | ||
| Q3 24 | $800.9M | $-344.1M | ||
| Q2 24 | $816.1M | $-203.2M | ||
| Q1 24 | $854.6M | $371.6M |
| Q4 25 | $1.2B | $308.9M | ||
| Q3 25 | $1.2B | $362.6M | ||
| Q2 25 | $1.3B | $379.2M | ||
| Q1 25 | $1.3B | $405.1M | ||
| Q4 24 | $1.3B | $437.4M | ||
| Q3 24 | $1.4B | $537.8M | ||
| Q2 24 | $1.3B | $691.5M | ||
| Q1 24 | $1.4B | $1.3B |
| Q4 25 | 0.75× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.67× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.55× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.6M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.6M | $8.2M | ||
| Q3 25 | $5.7M | $11.4M | ||
| Q2 25 | $11.6M | $-21.3M | ||
| Q1 25 | $-2.2M | $8.5M | ||
| Q4 24 | $54.3M | $-14.7M | ||
| Q3 24 | $13.8M | $-9.4M | ||
| Q2 24 | $17.0M | $-11.9M | ||
| Q1 24 | $11.0M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
